Stay updated with breaking news from Clinical Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Company advances innovative rare disease and immuno-oncology portfolio toward ‘4x24’ goal of four registrational programs in 2024 – – Poster presentation at ASCO 2022... | May 16, 2022
Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.